Intake Screening and Withdrawal Management

Executive frame

The central challenge is to make a complex rule usable without pretending that its boundaries have disappeared. Intake Screening and Withdrawal Management addresses a field in which booking question, receiving screen, clinical intake, comprehensive assessment, withdrawal risk, withdrawal syndrome, intoxication, medication verification, observation, and hospital transfer can be collapsed into one another. Intake is a time-critical clinical transition, not a booking checkbox: safe policy links immediate observation, validated screening, medication and substance history, alcohol and sedative risk, opioid withdrawal, pregnancy, suicide and medical red flags, records and pharmacy verification, serial reassessment, treatment, emergency transfer, and continuity. The point is not to make action impossible. It is to make the reason for action visible, reviewable, and capable of being corrected when the facts, law, technology, or implementation change.

The working map for this article is arrival and custody handoff → immediate red-flag observation → validated screen → medication and record verification → risk stratification → housing, monitoring, and treatment → serial reassessment → escalation or transfer → stabilization, ongoing treatment, and quality review. That sequence identifies more than chronology. It locates the actor who can create or alter a record, the rule applicable at that stage, the people who may be affected, and the point at which an error becomes harder to reverse. Reading the chain forward prevents a later result from being projected backward onto an earlier allegation, signal, permission, technical event, or proposal.

The mechanism analysis centers on custodial status, receiving screening, alcohol and sedative withdrawal, opioid withdrawal and OUD medication, pregnancy, diabetes and other acute illness, suicide risk, language and disability access, medication continuity, observation, housing, transport, and documentation. Each mechanism can produce a similar surface outcome through a different route. A delay may reflect capacity, a lawful review step, incompatible technology, missing information, strategic behavior, or an invalid barrier. A disclosure may be required, permitted, prohibited, mistakenly transmitted, or technically unavoidable in a limited emergency. Policy evaluation must identify the route before assigning responsibility or proposing a remedy.

The principal people and institutions are people entering custody; booking and custody staff; nurses, physicians, behavioral-health and pharmacy teams; EMS and hospitals; community prescribers; jail administrators; courts; DOJ; and families. They do not hold the same information or authority. A patient may know the consequence without seeing an internal rule; a regulator may know the governing process without observing frontline work; a vendor may know the system design without controlling how a customer configured it. The article therefore treats interviews as perspective and mechanism evidence, then uses primary records to verify legal status, dates, scope, and decisive facts.

A useful performance account includes time to first screen and clinician, screening completion with exclusions, medication verification, withdrawal-risk identification, monitoring compliance, treatment initiation, hospital transfer, seizure and delirium, overdose, suicide attempt, death, missed diagnosis, false reassurance, and corrective action. Those measures require defined units, populations, observation periods, missingness rules, and version history. A raw count cannot by itself distinguish greater underlying harm from better detection, broader jurisdiction, easier reporting, duplicate records, changed coding, or backlog clearance. Where causal evidence is unavailable, the article states the uncertainty and specifies what additional observation would help resolve it.

The guardrails are equally important: Do not use one negative screen to close clinical observation; do not punish withdrawal symptoms as misconduct; do not delay hospital transfer for administrative authorization. Those limits keep a valuable reform from becoming a new source of harm. The recommended direction—a layered intake-and-withdrawal safety system with immediate observation, validated tools, rapid clinician access, pharmacy and record continuity, risk-based monitoring and treatment, emergency transfer, custody-health communication, and mortality-linked improvement—should therefore be implemented with named owners, realistic capacity, a visible exception or review route, and measures that can reveal both benefit and burden. A policy earns confidence by surviving correction, not by avoiding it.

Definitions, authority, and scope

For Intake Screening and Withdrawal Management, the most important definitions are functional. A legal rule states what an authorized source requires, permits, or prohibits; guidance explains administration without automatically carrying the same force; an operational policy tells an institution how it will act; a technical control constrains or records system behavior; and a recommendation states what this article concludes should change. One document may discuss several layers, but the resulting sentences should not merge them.

In Intake Screening and Withdrawal Management, the phrase source competent to establish the claim means the current instrument closest to the proposition: statutory or regulatory text for legal authority, an operative order for a case outcome, a system or audit record for a transaction, an originating dataset and documentation for a quantitative result, and direct testimony for personal experience. Summaries are helpful navigation. They are not substitutes when definitions, exceptions, effective dates, procedural posture, or current litigation status control the answer.

A scope boundary identifies jurisdiction, actor, population, program, record type, purpose, time, and version. Here the jurisdiction is U.S. jail and prison intake, withdrawal management, constitutional law, addiction medicine, emergency transfer, and international prison-health systems. The same data or conduct may be governed differently when one of those coordinates changes. A responsible comparison preserves the coordinate that matters instead of exporting a federal rule to an uncovered actor, a state exception to another jurisdiction, or a program result to the full health system.

A governance control assigns a decision right and creates evidence that the decision was performed. Policies without an owner, data inventory, training, escalation path, review clock, audit record, and correction route can be aspirational but are not reliably operational. For Intake Screening and Withdrawal Management, governance quality should be assessed by whether affected people can understand the rule, whether responsible staff can execute it under ordinary workload, and whether a reviewer can reconstruct what happened after an adverse outcome.

Why intake is a clinical transition

Why intake is a clinical transition should be treated first as a problem of workflow reconstruction. In Intake Screening and Withdrawal Management, the analyst should identify the concrete decision, the actor with authority, the affected record or service, and the consequence of a false positive, false negative, or delayed result. The relevant boundary is among booking question, receiving screen, clinical intake, comprehensive assessment, withdrawal risk, withdrawal syndrome, intoxication, medication verification, observation, and hospital transfer. A useful interview question asks the participant to describe the last actual case step by step, including the form, screen, queue, message, exception, and person who could change the outcome. That reconstruction often reveals where a broad policy label stopped matching work as performed.

The first primary-source anchor is U.S. Bureau of Justice Assistance — Guidelines for Managing Substance Withdrawal in Jails. It establishes a bounded proposition: BJA and NIC guidance addresses intake screening, risk identification, monitoring, clinical escalation, medication, transfer, documentation, and shared custody-health responsibilities for withdrawal in jails. Its limitation is just as material: The guidelines state that views do not necessarily constitute binding DOJ policy; they do not replace state law, clinical judgment, licensing rules, or emergency transfer standards. Applied to why intake is a clinical transition, the authority should be cited for the precise proposition it can establish, with its issuer, status, date, affected entities, and operative terminology preserved. If a current regulation, statute, court order, or implementation notice differs from a general summary, the controlling or more current source should govern the sentence and the discrepancy should be recorded for editorial review.

The predictable failure mode is that an informal shortcut becomes a durable rule without review. Measurement should therefore connect the issue to time to first screen and clinician, screening completion with exclusions, medication verification, withdrawal-risk identification, monitoring compliance, treatment initiation, hospital transfer, seizure and delirium, overdose, suicide attempt, death, missed diagnosis, false reassurance, and corrective action. For why intake is a clinical transition, define the unit and population before calculating a rate; distinguish intake from disposition cohorts; show median and tail performance where delay matters; and document duplicates, exclusions, suppressed small cells, missing fields, changed definitions, and revisions. Compare groups only when coverage and ascertainment are sufficiently similar. If the evidence cannot support a causal or comparative claim, report the observable process result and state the unanswered causal question rather than filling it with an impression.

Implementation should assign an owner, required evidence, decision clock, exception path, audit record, and correction trigger for why intake is a clinical transition. The design must account for custodial status, receiving screening, alcohol and sedative withdrawal, opioid withdrawal and OUD medication, pregnancy, diabetes and other acute illness, suicide risk, language and disability access, medication continuity, observation, housing, transport, and documentation and should be tested with people entering custody; booking and custody staff; nurses, physicians, behavioral-health and pharmacy teams; EMS and hospitals; community prescribers; jail administrators; courts; DOJ; and families. The practical review asks whether a person can obtain notice where lawful, understand the basis, provide contrary information, request accommodation or urgency, receive reasons, and correct every downstream use that relied on an error. Capacity—staff, language services, accessibility, clinical expertise, security, procurement, and vendor cooperation—is part of validity in practice. The safeguard remains bounded by this article's red lines: Do not use one negative screen to close clinical observation; do not punish withdrawal symptoms as misconduct; do not delay hospital transfer for administrative authorization.

Immediate observation and red flags

Immediate observation and red flags should be treated first as a problem of measurement and feedback. In Intake Screening and Withdrawal Management, the analyst should identify the concrete decision, the actor with authority, the affected record or service, and the consequence of a false positive, false negative, or delayed result. The relevant boundary is among booking question, receiving screen, clinical intake, comprehensive assessment, withdrawal risk, withdrawal syndrome, intoxication, medication verification, observation, and hospital transfer. A useful interview question asks the participant to describe the last actual case step by step, including the form, screen, queue, message, exception, and person who could change the outcome. That reconstruction often reveals where a broad policy label stopped matching work as performed.

The first primary-source anchor is U.S. Bureau of Justice Assistance — Managing Substance Withdrawal in Jails: A Legal Brief. It establishes a bounded proposition: BJA summarizes legal risks and operational lessons relevant to withdrawal screening and management in local jails. Its limitation is just as material: The brief is educational, not controlling precedent; governing constitutional standards vary by custodial status, circuit, facts, actor, and claim. Applied to immediate observation and red flags, the authority should be cited for the precise proposition it can establish, with its issuer, status, date, affected entities, and operative terminology preserved. If a current regulation, statute, court order, or implementation notice differs from a general summary, the controlling or more current source should govern the sentence and the discrepancy should be recorded for editorial review.

The predictable failure mode is that a missing denominator turns activity into an apparent outcome. Measurement should therefore connect the issue to time to first screen and clinician, screening completion with exclusions, medication verification, withdrawal-risk identification, monitoring compliance, treatment initiation, hospital transfer, seizure and delirium, overdose, suicide attempt, death, missed diagnosis, false reassurance, and corrective action. For immediate observation and red flags, define the unit and population before calculating a rate; distinguish intake from disposition cohorts; show median and tail performance where delay matters; and document duplicates, exclusions, suppressed small cells, missing fields, changed definitions, and revisions. Compare groups only when coverage and ascertainment are sufficiently similar. If the evidence cannot support a causal or comparative claim, report the observable process result and state the unanswered causal question rather than filling it with an impression.

Implementation should assign an owner, required evidence, decision clock, exception path, audit record, and correction trigger for immediate observation and red flags. The design must account for custodial status, receiving screening, alcohol and sedative withdrawal, opioid withdrawal and OUD medication, pregnancy, diabetes and other acute illness, suicide risk, language and disability access, medication continuity, observation, housing, transport, and documentation and should be tested with people entering custody; booking and custody staff; nurses, physicians, behavioral-health and pharmacy teams; EMS and hospitals; community prescribers; jail administrators; courts; DOJ; and families. The practical review asks whether a person can obtain notice where lawful, understand the basis, provide contrary information, request accommodation or urgency, receive reasons, and correct every downstream use that relied on an error. Capacity—staff, language services, accessibility, clinical expertise, security, procurement, and vendor cooperation—is part of validity in practice. The safeguard remains bounded by this article's red lines: Do not use one negative screen to close clinical observation; do not punish withdrawal symptoms as misconduct; do not delay hospital transfer for administrative authorization.

Validated screening and its limits

Validated screening and its limits should be treated first as a problem of rights, exceptions, and review. In Intake Screening and Withdrawal Management, the analyst should identify the concrete decision, the actor with authority, the affected record or service, and the consequence of a false positive, false negative, or delayed result. The relevant boundary is among booking question, receiving screen, clinical intake, comprehensive assessment, withdrawal risk, withdrawal syndrome, intoxication, medication verification, observation, and hospital transfer. A useful interview question asks the participant to describe the last actual case step by step, including the form, screen, queue, message, exception, and person who could change the outcome. That reconstruction often reveals where a broad policy label stopped matching work as performed.

The first primary-source anchor is U.S. Supreme Court — Estelle v. Gamble, 429 U.S. 97 (1976). It establishes a bounded proposition: Estelle held that deliberate indifference to serious medical needs can violate the Eighth Amendment while negligence or disagreement with treatment does not automatically establish a constitutional violation. Its limitation is just as material: The holding addresses convicted prisoners under the Eighth Amendment; state tort, licensing, statutory, accreditation, and pretrial-detainee standards are separate. Applied to validated screening and its limits, the authority should be cited for the precise proposition it can establish, with its issuer, status, date, affected entities, and operative terminology preserved. If a current regulation, statute, court order, or implementation notice differs from a general summary, the controlling or more current source should govern the sentence and the discrepancy should be recorded for editorial review.

The predictable failure mode is that a missing denominator turns activity into an apparent outcome. Measurement should therefore connect the issue to time to first screen and clinician, screening completion with exclusions, medication verification, withdrawal-risk identification, monitoring compliance, treatment initiation, hospital transfer, seizure and delirium, overdose, suicide attempt, death, missed diagnosis, false reassurance, and corrective action. For validated screening and its limits, define the unit and population before calculating a rate; distinguish intake from disposition cohorts; show median and tail performance where delay matters; and document duplicates, exclusions, suppressed small cells, missing fields, changed definitions, and revisions. Compare groups only when coverage and ascertainment are sufficiently similar. If the evidence cannot support a causal or comparative claim, report the observable process result and state the unanswered causal question rather than filling it with an impression.

Implementation should assign an owner, required evidence, decision clock, exception path, audit record, and correction trigger for validated screening and its limits. The design must account for custodial status, receiving screening, alcohol and sedative withdrawal, opioid withdrawal and OUD medication, pregnancy, diabetes and other acute illness, suicide risk, language and disability access, medication continuity, observation, housing, transport, and documentation and should be tested with people entering custody; booking and custody staff; nurses, physicians, behavioral-health and pharmacy teams; EMS and hospitals; community prescribers; jail administrators; courts; DOJ; and families. The practical review asks whether a person can obtain notice where lawful, understand the basis, provide contrary information, request accommodation or urgency, receive reasons, and correct every downstream use that relied on an error. Capacity—staff, language services, accessibility, clinical expertise, security, procurement, and vendor cooperation—is part of validity in practice. The safeguard remains bounded by this article's red lines: Do not use one negative screen to close clinical observation; do not punish withdrawal symptoms as misconduct; do not delay hospital transfer for administrative authorization.

Medication and record verification

Medication and record verification should be treated first as a problem of implementation ownership. In Intake Screening and Withdrawal Management, the analyst should identify the concrete decision, the actor with authority, the affected record or service, and the consequence of a false positive, false negative, or delayed result. The relevant boundary is among booking question, receiving screen, clinical intake, comprehensive assessment, withdrawal risk, withdrawal syndrome, intoxication, medication verification, observation, and hospital transfer. A useful interview question asks the participant to describe the last actual case step by step, including the form, screen, queue, message, exception, and person who could change the outcome. That reconstruction often reveals where a broad policy label stopped matching work as performed.

The first primary-source anchor is U.S. Court of Appeals for the Ninth Circuit — Gordon v. County of Orange. It establishes a bounded proposition: Gordon applies an objective deliberate-indifference framework to Fourteenth Amendment inadequate-medical-care claims by pretrial detainees in the Ninth Circuit. Its limitation is just as material: The opinion is circuit authority, not a nationwide Supreme Court holding; elements, qualified immunity, municipal liability, causation, and later cases must be analyzed separately. Applied to medication and record verification, the authority should be cited for the precise proposition it can establish, with its issuer, status, date, affected entities, and operative terminology preserved. If a current regulation, statute, court order, or implementation notice differs from a general summary, the controlling or more current source should govern the sentence and the discrepancy should be recorded for editorial review.

The predictable failure mode is that a narrow permission expands into an unstated general practice. Measurement should therefore connect the issue to time to first screen and clinician, screening completion with exclusions, medication verification, withdrawal-risk identification, monitoring compliance, treatment initiation, hospital transfer, seizure and delirium, overdose, suicide attempt, death, missed diagnosis, false reassurance, and corrective action. For medication and record verification, define the unit and population before calculating a rate; distinguish intake from disposition cohorts; show median and tail performance where delay matters; and document duplicates, exclusions, suppressed small cells, missing fields, changed definitions, and revisions. Compare groups only when coverage and ascertainment are sufficiently similar. If the evidence cannot support a causal or comparative claim, report the observable process result and state the unanswered causal question rather than filling it with an impression.

Implementation should assign an owner, required evidence, decision clock, exception path, audit record, and correction trigger for medication and record verification. The design must account for custodial status, receiving screening, alcohol and sedative withdrawal, opioid withdrawal and OUD medication, pregnancy, diabetes and other acute illness, suicide risk, language and disability access, medication continuity, observation, housing, transport, and documentation and should be tested with people entering custody; booking and custody staff; nurses, physicians, behavioral-health and pharmacy teams; EMS and hospitals; community prescribers; jail administrators; courts; DOJ; and families. The practical review asks whether a person can obtain notice where lawful, understand the basis, provide contrary information, request accommodation or urgency, receive reasons, and correct every downstream use that relied on an error. Capacity—staff, language services, accessibility, clinical expertise, security, procurement, and vendor cooperation—is part of validity in practice. The safeguard remains bounded by this article's red lines: Do not use one negative screen to close clinical observation; do not punish withdrawal symptoms as misconduct; do not delay hospital transfer for administrative authorization.

Alcohol and sedative withdrawal

Alcohol and sedative withdrawal should be treated first as a problem of classification and authority. In Intake Screening and Withdrawal Management, the analyst should identify the concrete decision, the actor with authority, the affected record or service, and the consequence of a false positive, false negative, or delayed result. The relevant boundary is among booking question, receiving screen, clinical intake, comprehensive assessment, withdrawal risk, withdrawal syndrome, intoxication, medication verification, observation, and hospital transfer. A useful interview question asks the participant to describe the last actual case step by step, including the form, screen, queue, message, exception, and person who could change the outcome. That reconstruction often reveals where a broad policy label stopped matching work as performed.

The first primary-source anchor is World Health Organization — Organizational Models of Prison Health. It establishes a bounded proposition: WHO compares governance models for prison health, including health-ministry integration, continuity, screening, clinical independence, and withdrawal response. Its limitation is just as material: The report reflects international models and cannot be imported without domestic authority, financing, workforce, data, custody, and implementation analysis. Applied to alcohol and sedative withdrawal, the authority should be cited for the precise proposition it can establish, with its issuer, status, date, affected entities, and operative terminology preserved. If a current regulation, statute, court order, or implementation notice differs from a general summary, the controlling or more current source should govern the sentence and the discrepancy should be recorded for editorial review.

The predictable failure mode is that a technical limitation is reported as though the law required it. Measurement should therefore connect the issue to time to first screen and clinician, screening completion with exclusions, medication verification, withdrawal-risk identification, monitoring compliance, treatment initiation, hospital transfer, seizure and delirium, overdose, suicide attempt, death, missed diagnosis, false reassurance, and corrective action. For alcohol and sedative withdrawal, define the unit and population before calculating a rate; distinguish intake from disposition cohorts; show median and tail performance where delay matters; and document duplicates, exclusions, suppressed small cells, missing fields, changed definitions, and revisions. Compare groups only when coverage and ascertainment are sufficiently similar. If the evidence cannot support a causal or comparative claim, report the observable process result and state the unanswered causal question rather than filling it with an impression.

Implementation should assign an owner, required evidence, decision clock, exception path, audit record, and correction trigger for alcohol and sedative withdrawal. The design must account for custodial status, receiving screening, alcohol and sedative withdrawal, opioid withdrawal and OUD medication, pregnancy, diabetes and other acute illness, suicide risk, language and disability access, medication continuity, observation, housing, transport, and documentation and should be tested with people entering custody; booking and custody staff; nurses, physicians, behavioral-health and pharmacy teams; EMS and hospitals; community prescribers; jail administrators; courts; DOJ; and families. The practical review asks whether a person can obtain notice where lawful, understand the basis, provide contrary information, request accommodation or urgency, receive reasons, and correct every downstream use that relied on an error. Capacity—staff, language services, accessibility, clinical expertise, security, procurement, and vendor cooperation—is part of validity in practice. The safeguard remains bounded by this article's red lines: Do not use one negative screen to close clinical observation; do not punish withdrawal symptoms as misconduct; do not delay hospital transfer for administrative authorization.

Opioid withdrawal and medication for OUD

Opioid withdrawal and medication for OUD should be treated first as a problem of rights, exceptions, and review. In Intake Screening and Withdrawal Management, the analyst should identify the concrete decision, the actor with authority, the affected record or service, and the consequence of a false positive, false negative, or delayed result. The relevant boundary is among booking question, receiving screen, clinical intake, comprehensive assessment, withdrawal risk, withdrawal syndrome, intoxication, medication verification, observation, and hospital transfer. A useful interview question asks the participant to describe the last actual case step by step, including the form, screen, queue, message, exception, and person who could change the outcome. That reconstruction often reveals where a broad policy label stopped matching work as performed.

The first primary-source anchor is United Nations — Nelson Mandela Rules. It establishes a bounded proposition: The Nelson Mandela Rules address equivalence of care, clinical independence, continuity, urgent care, documentation, and health-service organization in prisons. Its limitation is just as material: The Rules are international standards, not self-executing U.S. constitutional law or a substitute for domestic statute, case law, licensing, and facility-specific facts. Applied to opioid withdrawal and medication for oud, the authority should be cited for the precise proposition it can establish, with its issuer, status, date, affected entities, and operative terminology preserved. If a current regulation, statute, court order, or implementation notice differs from a general summary, the controlling or more current source should govern the sentence and the discrepancy should be recorded for editorial review.

The predictable failure mode is that an exception intended for unusual cases becomes ordinary workflow. Measurement should therefore connect the issue to time to first screen and clinician, screening completion with exclusions, medication verification, withdrawal-risk identification, monitoring compliance, treatment initiation, hospital transfer, seizure and delirium, overdose, suicide attempt, death, missed diagnosis, false reassurance, and corrective action. For opioid withdrawal and medication for oud, define the unit and population before calculating a rate; distinguish intake from disposition cohorts; show median and tail performance where delay matters; and document duplicates, exclusions, suppressed small cells, missing fields, changed definitions, and revisions. Compare groups only when coverage and ascertainment are sufficiently similar. If the evidence cannot support a causal or comparative claim, report the observable process result and state the unanswered causal question rather than filling it with an impression.

Implementation should assign an owner, required evidence, decision clock, exception path, audit record, and correction trigger for opioid withdrawal and medication for oud. The design must account for custodial status, receiving screening, alcohol and sedative withdrawal, opioid withdrawal and OUD medication, pregnancy, diabetes and other acute illness, suicide risk, language and disability access, medication continuity, observation, housing, transport, and documentation and should be tested with people entering custody; booking and custody staff; nurses, physicians, behavioral-health and pharmacy teams; EMS and hospitals; community prescribers; jail administrators; courts; DOJ; and families. The practical review asks whether a person can obtain notice where lawful, understand the basis, provide contrary information, request accommodation or urgency, receive reasons, and correct every downstream use that relied on an error. Capacity—staff, language services, accessibility, clinical expertise, security, procurement, and vendor cooperation—is part of validity in practice. The safeguard remains bounded by this article's red lines: Do not use one negative screen to close clinical observation; do not punish withdrawal symptoms as misconduct; do not delay hospital transfer for administrative authorization.

Pregnancy, diabetes, suicide, and co-occurring risk

Pregnancy, diabetes, suicide, and co-occurring risk should be treated first as a problem of rights, exceptions, and review. In Intake Screening and Withdrawal Management, the analyst should identify the concrete decision, the actor with authority, the affected record or service, and the consequence of a false positive, false negative, or delayed result. The relevant boundary is among booking question, receiving screen, clinical intake, comprehensive assessment, withdrawal risk, withdrawal syndrome, intoxication, medication verification, observation, and hospital transfer. A useful interview question asks the participant to describe the last actual case step by step, including the form, screen, queue, message, exception, and person who could change the outcome. That reconstruction often reveals where a broad policy label stopped matching work as performed.

The first primary-source anchor is U.S. Bureau of Justice Assistance — Guidelines for Managing Substance Withdrawal in Jails. It establishes a bounded proposition: BJA and NIC guidance addresses intake screening, risk identification, monitoring, clinical escalation, medication, transfer, documentation, and shared custody-health responsibilities for withdrawal in jails. Its limitation is just as material: The guidelines state that views do not necessarily constitute binding DOJ policy; they do not replace state law, clinical judgment, licensing rules, or emergency transfer standards. Applied to pregnancy, diabetes, suicide, and co-occurring risk, the authority should be cited for the precise proposition it can establish, with its issuer, status, date, affected entities, and operative terminology preserved. If a current regulation, statute, court order, or implementation notice differs from a general summary, the controlling or more current source should govern the sentence and the discrepancy should be recorded for editorial review.

The predictable failure mode is that an exception intended for unusual cases becomes ordinary workflow. Measurement should therefore connect the issue to time to first screen and clinician, screening completion with exclusions, medication verification, withdrawal-risk identification, monitoring compliance, treatment initiation, hospital transfer, seizure and delirium, overdose, suicide attempt, death, missed diagnosis, false reassurance, and corrective action. For pregnancy, diabetes, suicide, and co-occurring risk, define the unit and population before calculating a rate; distinguish intake from disposition cohorts; show median and tail performance where delay matters; and document duplicates, exclusions, suppressed small cells, missing fields, changed definitions, and revisions. Compare groups only when coverage and ascertainment are sufficiently similar. If the evidence cannot support a causal or comparative claim, report the observable process result and state the unanswered causal question rather than filling it with an impression.

Implementation should assign an owner, required evidence, decision clock, exception path, audit record, and correction trigger for pregnancy, diabetes, suicide, and co-occurring risk. The design must account for custodial status, receiving screening, alcohol and sedative withdrawal, opioid withdrawal and OUD medication, pregnancy, diabetes and other acute illness, suicide risk, language and disability access, medication continuity, observation, housing, transport, and documentation and should be tested with people entering custody; booking and custody staff; nurses, physicians, behavioral-health and pharmacy teams; EMS and hospitals; community prescribers; jail administrators; courts; DOJ; and families. The practical review asks whether a person can obtain notice where lawful, understand the basis, provide contrary information, request accommodation or urgency, receive reasons, and correct every downstream use that relied on an error. Capacity—staff, language services, accessibility, clinical expertise, security, procurement, and vendor cooperation—is part of validity in practice. The safeguard remains bounded by this article's red lines: Do not use one negative screen to close clinical observation; do not punish withdrawal symptoms as misconduct; do not delay hospital transfer for administrative authorization.

Monitoring, housing, and custody-health communication

Monitoring, housing, and custody-health communication should be treated first as a problem of data provenance and purpose. In Intake Screening and Withdrawal Management, the analyst should identify the concrete decision, the actor with authority, the affected record or service, and the consequence of a false positive, false negative, or delayed result. The relevant boundary is among booking question, receiving screen, clinical intake, comprehensive assessment, withdrawal risk, withdrawal syndrome, intoxication, medication verification, observation, and hospital transfer. A useful interview question asks the participant to describe the last actual case step by step, including the form, screen, queue, message, exception, and person who could change the outcome. That reconstruction often reveals where a broad policy label stopped matching work as performed.

The first primary-source anchor is U.S. Bureau of Justice Assistance — Managing Substance Withdrawal in Jails: A Legal Brief. It establishes a bounded proposition: BJA summarizes legal risks and operational lessons relevant to withdrawal screening and management in local jails. Its limitation is just as material: The brief is educational, not controlling precedent; governing constitutional standards vary by custodial status, circuit, facts, actor, and claim. Applied to monitoring, housing, and custody-health communication, the authority should be cited for the precise proposition it can establish, with its issuer, status, date, affected entities, and operative terminology preserved. If a current regulation, statute, court order, or implementation notice differs from a general summary, the controlling or more current source should govern the sentence and the discrepancy should be recorded for editorial review.

The predictable failure mode is that an exception intended for unusual cases becomes ordinary workflow. Measurement should therefore connect the issue to time to first screen and clinician, screening completion with exclusions, medication verification, withdrawal-risk identification, monitoring compliance, treatment initiation, hospital transfer, seizure and delirium, overdose, suicide attempt, death, missed diagnosis, false reassurance, and corrective action. For monitoring, housing, and custody-health communication, define the unit and population before calculating a rate; distinguish intake from disposition cohorts; show median and tail performance where delay matters; and document duplicates, exclusions, suppressed small cells, missing fields, changed definitions, and revisions. Compare groups only when coverage and ascertainment are sufficiently similar. If the evidence cannot support a causal or comparative claim, report the observable process result and state the unanswered causal question rather than filling it with an impression.

Implementation should assign an owner, required evidence, decision clock, exception path, audit record, and correction trigger for monitoring, housing, and custody-health communication. The design must account for custodial status, receiving screening, alcohol and sedative withdrawal, opioid withdrawal and OUD medication, pregnancy, diabetes and other acute illness, suicide risk, language and disability access, medication continuity, observation, housing, transport, and documentation and should be tested with people entering custody; booking and custody staff; nurses, physicians, behavioral-health and pharmacy teams; EMS and hospitals; community prescribers; jail administrators; courts; DOJ; and families. The practical review asks whether a person can obtain notice where lawful, understand the basis, provide contrary information, request accommodation or urgency, receive reasons, and correct every downstream use that relied on an error. Capacity—staff, language services, accessibility, clinical expertise, security, procurement, and vendor cooperation—is part of validity in practice. The safeguard remains bounded by this article's red lines: Do not use one negative screen to close clinical observation; do not punish withdrawal symptoms as misconduct; do not delay hospital transfer for administrative authorization.

Emergency transfer and continuity

Emergency transfer and continuity should be treated first as a problem of risk allocation and remedy. In Intake Screening and Withdrawal Management, the analyst should identify the concrete decision, the actor with authority, the affected record or service, and the consequence of a false positive, false negative, or delayed result. The relevant boundary is among booking question, receiving screen, clinical intake, comprehensive assessment, withdrawal risk, withdrawal syndrome, intoxication, medication verification, observation, and hospital transfer. A useful interview question asks the participant to describe the last actual case step by step, including the form, screen, queue, message, exception, and person who could change the outcome. That reconstruction often reveals where a broad policy label stopped matching work as performed.

The first primary-source anchor is U.S. Supreme Court — Estelle v. Gamble, 429 U.S. 97 (1976). It establishes a bounded proposition: Estelle held that deliberate indifference to serious medical needs can violate the Eighth Amendment while negligence or disagreement with treatment does not automatically establish a constitutional violation. Its limitation is just as material: The holding addresses convicted prisoners under the Eighth Amendment; state tort, licensing, statutory, accreditation, and pretrial-detainee standards are separate. Applied to emergency transfer and continuity, the authority should be cited for the precise proposition it can establish, with its issuer, status, date, affected entities, and operative terminology preserved. If a current regulation, statute, court order, or implementation notice differs from a general summary, the controlling or more current source should govern the sentence and the discrepancy should be recorded for editorial review.

The predictable failure mode is that a label outlives the evidence and context that originally supported it. Measurement should therefore connect the issue to time to first screen and clinician, screening completion with exclusions, medication verification, withdrawal-risk identification, monitoring compliance, treatment initiation, hospital transfer, seizure and delirium, overdose, suicide attempt, death, missed diagnosis, false reassurance, and corrective action. For emergency transfer and continuity, define the unit and population before calculating a rate; distinguish intake from disposition cohorts; show median and tail performance where delay matters; and document duplicates, exclusions, suppressed small cells, missing fields, changed definitions, and revisions. Compare groups only when coverage and ascertainment are sufficiently similar. If the evidence cannot support a causal or comparative claim, report the observable process result and state the unanswered causal question rather than filling it with an impression.

Implementation should assign an owner, required evidence, decision clock, exception path, audit record, and correction trigger for emergency transfer and continuity. The design must account for custodial status, receiving screening, alcohol and sedative withdrawal, opioid withdrawal and OUD medication, pregnancy, diabetes and other acute illness, suicide risk, language and disability access, medication continuity, observation, housing, transport, and documentation and should be tested with people entering custody; booking and custody staff; nurses, physicians, behavioral-health and pharmacy teams; EMS and hospitals; community prescribers; jail administrators; courts; DOJ; and families. The practical review asks whether a person can obtain notice where lawful, understand the basis, provide contrary information, request accommodation or urgency, receive reasons, and correct every downstream use that relied on an error. Capacity—staff, language services, accessibility, clinical expertise, security, procurement, and vendor cooperation—is part of validity in practice. The safeguard remains bounded by this article's red lines: Do not use one negative screen to close clinical observation; do not punish withdrawal symptoms as misconduct; do not delay hospital transfer for administrative authorization.

Legal, national, and international accountability

Legal, national, and international accountability should be treated first as a problem of data provenance and purpose. In Intake Screening and Withdrawal Management, the analyst should identify the concrete decision, the actor with authority, the affected record or service, and the consequence of a false positive, false negative, or delayed result. The relevant boundary is among booking question, receiving screen, clinical intake, comprehensive assessment, withdrawal risk, withdrawal syndrome, intoxication, medication verification, observation, and hospital transfer. A useful interview question asks the participant to describe the last actual case step by step, including the form, screen, queue, message, exception, and person who could change the outcome. That reconstruction often reveals where a broad policy label stopped matching work as performed.

The first primary-source anchor is U.S. Court of Appeals for the Ninth Circuit — Gordon v. County of Orange. It establishes a bounded proposition: Gordon applies an objective deliberate-indifference framework to Fourteenth Amendment inadequate-medical-care claims by pretrial detainees in the Ninth Circuit. Its limitation is just as material: The opinion is circuit authority, not a nationwide Supreme Court holding; elements, qualified immunity, municipal liability, causation, and later cases must be analyzed separately. Applied to legal, national, and international accountability, the authority should be cited for the precise proposition it can establish, with its issuer, status, date, affected entities, and operative terminology preserved. If a current regulation, statute, court order, or implementation notice differs from a general summary, the controlling or more current source should govern the sentence and the discrepancy should be recorded for editorial review.

The predictable failure mode is that a label outlives the evidence and context that originally supported it. Measurement should therefore connect the issue to time to first screen and clinician, screening completion with exclusions, medication verification, withdrawal-risk identification, monitoring compliance, treatment initiation, hospital transfer, seizure and delirium, overdose, suicide attempt, death, missed diagnosis, false reassurance, and corrective action. For legal, national, and international accountability, define the unit and population before calculating a rate; distinguish intake from disposition cohorts; show median and tail performance where delay matters; and document duplicates, exclusions, suppressed small cells, missing fields, changed definitions, and revisions. Compare groups only when coverage and ascertainment are sufficiently similar. If the evidence cannot support a causal or comparative claim, report the observable process result and state the unanswered causal question rather than filling it with an impression.

Implementation should assign an owner, required evidence, decision clock, exception path, audit record, and correction trigger for legal, national, and international accountability. The design must account for custodial status, receiving screening, alcohol and sedative withdrawal, opioid withdrawal and OUD medication, pregnancy, diabetes and other acute illness, suicide risk, language and disability access, medication continuity, observation, housing, transport, and documentation and should be tested with people entering custody; booking and custody staff; nurses, physicians, behavioral-health and pharmacy teams; EMS and hospitals; community prescribers; jail administrators; courts; DOJ; and families. The practical review asks whether a person can obtain notice where lawful, understand the basis, provide contrary information, request accommodation or urgency, receive reasons, and correct every downstream use that relied on an error. Capacity—staff, language services, accessibility, clinical expertise, security, procurement, and vendor cooperation—is part of validity in practice. The safeguard remains bounded by this article's red lines: Do not use one negative screen to close clinical observation; do not punish withdrawal symptoms as misconduct; do not delay hospital transfer for administrative authorization.

Cross-cutting governance tests

Authority and status. Every material claim in Intake Screening and Withdrawal Management should be tagged as controlling law, operative order, current agency position, technical standard, contractual rule, dataset, research evidence, attributed experience, inference, or proposal. That tag determines the verb. A court's vacatur, an agency's extension, a final rule's compliance date, or an unfinished rulemaking must appear next to the affected proposition rather than in a remote caveat.

Data and workflow provenance. The record path is arrival and custody handoff → immediate red-flag observation → validated screen → medication and record verification → risk stratification → housing, monitoring, and treatment → serial reassessment → escalation or transfer → stabilization, ongoing treatment, and quality review. Preserve who created each element, when, from which system or authority, for what purpose, and after what transformation. Where a derived field, dashboard, risk score, or summary drives action, retain a route to the underlying evidence. Lack of a public record should be described as an access limit, not proof that no confidential event or lawful restriction exists.

Purpose and proportionality. A rule designed for one purpose should not silently expand to another. For Intake Screening and Withdrawal Management, compare the information collected and consequence imposed with the stated public objective. A preliminary signal may justify review but not a durable adverse label. An emergency exception may justify temporary access but not indefinite retention or unrelated reuse. Stronger and less reversible consequences require stronger evidence, reasons, human authority, and meaningful review.

Distribution and accessibility. For Intake Screening and Withdrawal Management, average results can conceal predictable barriers associated with geography, language, disability, income, digital access, institutional size, or ability to wait. Analyze the mechanism before publishing a subgroup comparison. Determine whether the proposal changes access to information, clinical services, representation, appeals, correction, transportation, or technical support, and whether the relevant institution has authority and resources to repair the identified pathway.

Security, privacy, and continuity. Confidentiality is not a reason to omit operational planning, and transparency is not a license to disclose sensitive records. Intake Screening and Withdrawal Management requires role-based access, minimum necessary information where applicable, secure exchange, reliable availability, incident response, lawful public reporting, retention control, and a method for continuing critical work when technology or a vendor fails. Each objective should be tied to a responsible owner rather than assigned to an abstract system.

Correction and learning. The Intake Screening and Withdrawal Management audit trail should contain the source, status, version, actor, criteria, affected population, decision, reason, exception, reviewer, and correction history. A correction is incomplete if it changes only the originating page while a portal, report, search result, recipient database, clinical decision, or public label continues to carry the error. Recurring corrections should produce a root-cause review and a change to policy, training, technology, staffing, or oversight.

Ten-step verification and implementation protocol

1. State the exact legal, factual, technical, causal, and normative claims being evaluated in Intake Screening and Withdrawal Management.
2. Fix the jurisdiction and coordinates: U.S. jail and prison intake, withdrawal management, constitutional law, addiction medicine, emergency transfer, and international prison-health systems.
3. Identify the decision-maker, data controller, operational owner, affected population, consequence, and available remedy.
4. Locate current primary authorities and record source type, status, version, effective or compliance date, litigation status, and scope.
5. Reconstruct the workflow without skipping stages: arrival and custody handoff → immediate red-flag observation → validated screen → medication and record verification → risk stratification → housing, monitoring, and treatment → serial reassessment → escalation or transfer → stabilization, ongoing treatment, and quality review.
6. Test the operative mechanisms, including custodial status, receiving screening, alcohol and sedative withdrawal, opioid withdrawal and OUD medication, pregnancy, diabetes and other acute illness, suicide risk, language and disability access, medication continuity, observation, housing, transport, and documentation.
7. Select outcome, process, balancing, and distribution measures from this set: time to first screen and clinician, screening completion with exclusions, medication verification, withdrawal-risk identification, monitoring compliance, treatment initiation, hospital transfer, seizure and delirium, overdose, suicide attempt, death, missed diagnosis, false reassurance, and corrective action.
8. Seek later history, disconfirming evidence, alternative mechanisms, edge cases, and perspectives from differently situated participants.
9. Draft with status-accurate verbs, nearby citations, explicit uncertainty, and a visible distinction between official source and original recommendation.
10. Reopen every link, recheck numbers and current status, confirm review and correction routes, and timestamp the final public version.

Failure modes that should stop publication or implementation

• Treating booking question, receiving screen, clinical intake, comprehensive assessment, withdrawal risk, withdrawal syndrome, intoxication, medication verification, observation, and hospital transfer as though the categories carry the same authority or consequence.
• Using a summary, press release, dashboard, or vendor statement where current controlling text or originating data are necessary.
• Converting a proposal, allegation, technical capability, voluntary framework, or selected enforcement action into a universal final rule.
• Publishing a total or ranking without the unit, relevant exposure population, time cohort, ascertainment limits, and revision history.
• Ignoring an effective date, compliance transition, injunction, vacatur, extension, state-law overlay, contract, or later correction.
• Adopting a reform without confronting its operational mechanisms: custodial status, receiving screening, alcohol and sedative withdrawal, opioid withdrawal and OUD medication, pregnancy, diabetes and other acute illness, suicide risk, language and disability access, medication continuity, observation, housing, transport, and documentation.
• Failing to include or account for the relevant participants: people entering custody; booking and custody staff; nurses, physicians, behavioral-health and pharmacy teams; EMS and hospitals; community prescribers; jail administrators; courts; DOJ; and families.
• Crossing these substantive boundaries: Do not use one negative screen to close clinical observation; do not punish withdrawal symptoms as misconduct; do not delay hospital transfer for administrative authorization.

Questions for boards, agencies, health systems, and reporters

• What exact action, right, restriction, data flow, or outcome is at issue in Intake Screening and Withdrawal Management?
• Which institution has legal authority, which has information, which operates the workflow, and which can repair the result?
• What is the current primary source, what is its legal or evidentiary status, and what does it leave unanswered?
• Which population, program, data class, purpose, jurisdiction, time, and technology version are inside the claim?
• Where can the workflow fail along this path: arrival and custody handoff → immediate red-flag observation → validated screen → medication and record verification → risk stratification → housing, monitoring, and treatment → serial reassessment → escalation or transfer → stabilization, ongoing treatment, and quality review?
• Which of these mechanisms is actually operating: custodial status, receiving screening, alcohol and sedative withdrawal, opioid withdrawal and OUD medication, pregnancy, diabetes and other acute illness, suicide risk, language and disability access, medication continuity, observation, housing, transport, and documentation?
• What would a plausible competing explanation predict, and which record could distinguish it?
• Are the proposed measures sufficient to reveal benefit, error, delay, burden, and distribution: time to first screen and clinician, screening completion with exclusions, medication verification, withdrawal-risk identification, monitoring compliance, treatment initiation, hospital transfer, seizure and delirium, overdose, suicide attempt, death, missed diagnosis, false reassurance, and corrective action?
• Can an affected person understand the basis, obtain needed access or accommodation, present contrary information, and receive a reasoned response?
• How will an error be corrected in the source record and in every important downstream use?
• What staffing, expertise, technology, translation, accessibility, security, procurement, or interagency capacity is assumed?
• What evidence would require the institution to pause, narrow, reverse, or retire the policy?

Reform direction

The recommended direction is a layered intake-and-withdrawal safety system with immediate observation, validated tools, rapid clinician access, pharmacy and record continuity, risk-based monitoring and treatment, emergency transfer, custody-health communication, and mortality-linked improvement. Implementation should begin with a written objective, a current authority map, named decision and operational owners, and a specification of the population and outcome being protected. The design should identify dependencies and failure recovery rather than assigning responsibility to the final worker, the patient, or a vendor whose contract does not match its practical control.

The implementation model must address custodial status, receiving screening, alcohol and sedative withdrawal, opioid withdrawal and OUD medication, pregnancy, diabetes and other acute illness, suicide risk, language and disability access, medication continuity, observation, housing, transport, and documentation. For each mechanism, leaders should define the expected control, the evidence that the control operated, an exception or escalation path, and the person who reviews failure. Pilot testing should include ordinary workload, urgent cases, uncommon data or languages, accessibility needs, small and less-resourced organizations, vendor outages, and conflicting authority. A policy that works only in a demonstration environment should not be represented as system capacity.

Evaluation should publish definitions and use time to first screen and clinician, screening completion with exclusions, medication verification, withdrawal-risk identification, monitoring compliance, treatment initiation, hospital transfer, seizure and delirium, overdose, suicide attempt, death, missed diagnosis, false reassurance, and corrective action. Results should be shown with appropriate denominators, cohorts, severity, tail delay, missingness, uncertainty, revisions, and distribution where reliable. Activity measures can explain workload but should not substitute for protection, access, accuracy, continuity, fairness, or durable correction. Independent review is most credible when its methods, access, conflicts, disagreements, and institutional response are documented.

Finally, implementation should make the boundaries enforceable: Do not use one negative screen to close clinical observation; do not punish withdrawal symptoms as misconduct; do not delay hospital transfer for administrative authorization. Affected people need a usable route for questions, urgency, accommodation, access, challenge, and correction. Leaders should review adverse events, appeals, overrides, disparities, workarounds, security incidents, vendor changes, and source updates on a scheduled cycle. Adoption is the beginning of evidence, not the end; failure to produce the expected outcomes should trigger revision rather than a search for a more flattering metric.

Conclusion

Intake is a time-critical clinical transition, not a booking checkbox: safe policy links immediate observation, validated screening, medication and substance history, alcohol and sedative risk, opioid withdrawal, pregnancy, suicide and medical red flags, records and pharmacy verification, serial reassessment, treatment, emergency transfer, and continuity. The conclusion is intentionally narrower than a slogan because Intake Screening and Withdrawal Management crosses legal, technical, clinical, administrative, and human boundaries. Each layer requires the source competent to establish it and a workflow capable of carrying the rule into ordinary practice.

The policy choice should be tested through time to first screen and clinician, screening completion with exclusions, medication verification, withdrawal-risk identification, monitoring compliance, treatment initiation, hospital transfer, seizure and delirium, overdose, suicide attempt, death, missed diagnosis, false reassurance, and corrective action. Those measures can reveal whether the reform protected people, improved access or accuracy, reduced preventable delay, and avoided transferring burden. They also create a basis for correction. When a later source, revised dataset, incident, appeal, or patient experience contradicts the expected result, governance should make revision possible before the error becomes normal practice.

A skeptical reader should be able to reconstruct every major claim in Intake Screening and Withdrawal Management from current authority to operational mechanism to measured outcome. Law remains law, guidance remains guidance, technology remains a tool, evidence retains its limits, and the recommendation remains the author's analysis. That disciplined separation is how a long-form policy article can be both useful now and correctable later.

National and international expert synthesis

National architecture. The U.S. policy problem is not simply whether one program exists; it is whether authority, payment, workforce, information, clinical responsibility, and remedy align across federal, state, local, Tribal, public, and private institutions. For Intake Screening and Withdrawal Management, the national anchor is U.S. Bureau of Justice Assistance — Guidelines for Managing Substance Withdrawal in Jails: BJA and NIC guidance addresses intake screening, risk identification, monitoring, clinical escalation, medication, transfer, documentation, and shared custody-health responsibilities for withdrawal in jails. The limit must remain visible: The guidelines state that views do not necessarily constitute binding DOJ policy; they do not replace state law, clinical judgment, licensing rules, or emergency transfer standards. A national strategy should therefore publish the legal and operational layer at which each intervention acts, identify who controls implementation, and measure whether the intended benefit reaches people across geography and institutional capacity.

Comparative international lens. For Intake Screening and Withdrawal Management, international comparison is useful when it exposes a design choice, not when another country's label is imported as proof. The relevant U.S. jurisdictional frame is U.S. jail and prison intake, withdrawal management, constitutional law, addiction medicine, emergency transfer, and international prison-health systems, and the analysis must preserve the distinction among booking question, receiving screen, clinical intake, comprehensive assessment, withdrawal risk, withdrawal syndrome, intoxication, medication verification, observation, and hospital transfer. World Health Organization — Organizational Models of Prison Health contributes this bounded proposition: WHO compares governance models for prison health, including health-ministry integration, continuity, screening, clinical independence, and withdrawal response. Its limitation is equally important: The report reflects international models and cannot be imported without domestic authority, financing, workforce, data, custody, and implementation analysis. The comparative question is which function the other system performs—financing, regionalization, workforce support, clinical independence, access measurement, or continuity—and which U.S. institution would need lawful authority, resources, and accountability to perform the analogous function.

Physician-policy perspective. A clinically serious analysis begins at the point where policy changes a real decision: who is seen, how quickly, by whom, with what information and capability, what happens when the first plan fails, and who remains responsible for follow-up. That perspective prevents finance, technology, regulation, and contract design from being evaluated in isolation. It also guards against the opposite error of treating every access problem as a request for more clinical labor. The full mechanism is custodial status, receiving screening, alcohol and sedative withdrawal, opioid withdrawal and OUD medication, pregnancy, diabetes and other acute illness, suicide risk, language and disability access, medication continuity, observation, housing, transport, and documentation; the relevant participants are people entering custody; booking and custody staff; nurses, physicians, behavioral-health and pharmacy teams; EMS and hospitals; community prescribers; jail administrators; courts; DOJ; and families. The policy must work during ordinary workload, high-acuity exceptions, staff turnover, technology failure, and transitions between institutions.

A falsifiable leadership agenda. National and international authority is earned by making recommendations testable. For this topic, leaders should precommit to time to first screen and clinician, screening completion with exclusions, medication verification, withdrawal-risk identification, monitoring compliance, treatment initiation, hospital transfer, seizure and delirium, overdose, suicide attempt, death, missed diagnosis, false reassurance, and corrective action. They should publish definitions, denominators, distribution, uncertainty, revisions, and the consequence that would trigger redesign. They should also enforce the substantive limits—Do not use one negative screen to close clinical observation; do not punish withdrawal symptoms as misconduct; do not delay hospital transfer for administrative authorization—because apparent improvement that depends on hidden exclusion, shifted burden, or weakened safeguards is not system improvement. This approach produces analysis that can travel across jurisdictions while remaining honest about what does not travel with it.

Sources and Authorities

Each source below was verified against the official publisher, current through August 10, 2026. Laws, proposed rules, and agency pages change; every link is re-opened live at deployment, and time-sensitive requirements should be checked against the current official source.

U.S. Bureau of Justice Assistance — Guidelines for Managing Substance Withdrawal in Jails

U.S. Bureau of Justice Assistance — Managing Substance Withdrawal in Jails: A Legal Brief

U.S. Supreme Court — Estelle v. Gamble, 429 U.S. 97 (1976)

U.S. Court of Appeals for the Ninth Circuit — Gordon v. County of Orange

World Health Organization — Organizational Models of Prison Health

United Nations — Nelson Mandela Rules

Related Articles

• Clinical Independence Behind Bars
• The Constitutional Floor for Correctional Health Care
• Medication Safety in Fragmented Systems